Frontlight ResearchEarly access
Frontotemporal dementia trials in Japan
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Where
- Bunkyō City
- Age
- 50 years to 85 years
- People
- 56 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06297590 · EU 2024-510604-37-00